While pharma has been using real-world data (RWD) to generate real-world evidence (RWE) for clinical trials, post-marketing, and R&D for decades, the emergence and applicability of RWD to the sales, marketing, and commercial side of the house is now ramping up. Many organizations are exploring the possibilities related to targeting, segmentation, sales force effectiveness, and adherence, allocating growing budgets to acquire, analyze, and visualize data.
How can pharma manufacturers leverage those resources to ensure they’re engaging HCPs and patients in a timely and precise manner? That’s where advanced analytics and execution in RWD translate into actionable insights that can drive positive outcomes. This webinar will discuss the current landscape based on recent research with pharma execs, use cases in pharma today, and future opportunities.
